Increased serum soluble IL-15Rα levels in T-cell large granular lymphocyte leukemia

Jing Chen, Mike Petrus, Richard Bamford, Joanna H. Shih, John C. Morris, John E. Janik, Thomas A. Waldmann

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Large granular lymphocyte (LGL) leukemia is a clonal lymphoproliferative disease of mature T and natural killer cells. The etiology of LGL leukemia is unknown. IL-15 is an inflammatory cytokine that stimulates T and natural killer cells and is critical for their survival and proliferation. IL-15 signals through a heterotrimeric receptor that is composed of a private receptor, IL-15Rα and IL-2/IL-15Rβ and γ c shared with IL-2. Using a newly developed assay, we demonstrated increased levels of soluble IL-15Rα in the serum of patients with T-LGL leukemia. Furthermore, IL-15Rα mRNA levels were also up-regulated in the PBMCs of these patients. FACS analysis indicated that IL-15Rα was expressed both on monocytes as well as on some CD8 + leukemic cells of the patients. Interestingly, themRNA levels of IFN-α, a known inducer of IL-15Rα, were also up-regulated in patients' PBMCs. Moreover, PBMCs of some T-LGL patients proliferated at higher levels in response to exogenously added IL-15 compared with those of normal donors. In summary, our study demonstrated increased expression of IL-15Rα in T-LGL leukemia. It is conceivable that higher IL-15Rα expression may lower IL-15 response threshold in vivo and, therefore, may contribute to the pathogenesis of the disease.

Original languageEnglish (US)
Pages (from-to)137-143
Number of pages7
JournalBlood
Volume119
Issue number1
DOIs
StatePublished - Jan 5 2012

Fingerprint

Large Granular Lymphocytic Leukemia
T-cells
Lymphocytes
Interleukin-15
Serum
Natural Killer T-Cells
Interleukin-2
Monocytes
Assays
Cells
Tissue Donors
Cytokines
Messenger RNA
Survival

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Chen, J., Petrus, M., Bamford, R., Shih, J. H., Morris, J. C., Janik, J. E., & Waldmann, T. A. (2012). Increased serum soluble IL-15Rα levels in T-cell large granular lymphocyte leukemia. Blood, 119(1), 137-143. https://doi.org/10.1182/blood-2011-04-346759

Increased serum soluble IL-15Rα levels in T-cell large granular lymphocyte leukemia. / Chen, Jing; Petrus, Mike; Bamford, Richard; Shih, Joanna H.; Morris, John C.; Janik, John E.; Waldmann, Thomas A.

In: Blood, Vol. 119, No. 1, 05.01.2012, p. 137-143.

Research output: Contribution to journalArticle

Chen, J, Petrus, M, Bamford, R, Shih, JH, Morris, JC, Janik, JE & Waldmann, TA 2012, 'Increased serum soluble IL-15Rα levels in T-cell large granular lymphocyte leukemia', Blood, vol. 119, no. 1, pp. 137-143. https://doi.org/10.1182/blood-2011-04-346759
Chen J, Petrus M, Bamford R, Shih JH, Morris JC, Janik JE et al. Increased serum soluble IL-15Rα levels in T-cell large granular lymphocyte leukemia. Blood. 2012 Jan 5;119(1):137-143. https://doi.org/10.1182/blood-2011-04-346759
Chen, Jing ; Petrus, Mike ; Bamford, Richard ; Shih, Joanna H. ; Morris, John C. ; Janik, John E. ; Waldmann, Thomas A. / Increased serum soluble IL-15Rα levels in T-cell large granular lymphocyte leukemia. In: Blood. 2012 ; Vol. 119, No. 1. pp. 137-143.
@article{9c0b70ca7f1948c1b5d329aa689b7ab0,
title = "Increased serum soluble IL-15Rα levels in T-cell large granular lymphocyte leukemia",
abstract = "Large granular lymphocyte (LGL) leukemia is a clonal lymphoproliferative disease of mature T and natural killer cells. The etiology of LGL leukemia is unknown. IL-15 is an inflammatory cytokine that stimulates T and natural killer cells and is critical for their survival and proliferation. IL-15 signals through a heterotrimeric receptor that is composed of a private receptor, IL-15Rα and IL-2/IL-15Rβ and γ c shared with IL-2. Using a newly developed assay, we demonstrated increased levels of soluble IL-15Rα in the serum of patients with T-LGL leukemia. Furthermore, IL-15Rα mRNA levels were also up-regulated in the PBMCs of these patients. FACS analysis indicated that IL-15Rα was expressed both on monocytes as well as on some CD8 + leukemic cells of the patients. Interestingly, themRNA levels of IFN-α, a known inducer of IL-15Rα, were also up-regulated in patients' PBMCs. Moreover, PBMCs of some T-LGL patients proliferated at higher levels in response to exogenously added IL-15 compared with those of normal donors. In summary, our study demonstrated increased expression of IL-15Rα in T-LGL leukemia. It is conceivable that higher IL-15Rα expression may lower IL-15 response threshold in vivo and, therefore, may contribute to the pathogenesis of the disease.",
author = "Jing Chen and Mike Petrus and Richard Bamford and Shih, {Joanna H.} and Morris, {John C.} and Janik, {John E.} and Waldmann, {Thomas A.}",
year = "2012",
month = "1",
day = "5",
doi = "10.1182/blood-2011-04-346759",
language = "English (US)",
volume = "119",
pages = "137--143",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "1",

}

TY - JOUR

T1 - Increased serum soluble IL-15Rα levels in T-cell large granular lymphocyte leukemia

AU - Chen, Jing

AU - Petrus, Mike

AU - Bamford, Richard

AU - Shih, Joanna H.

AU - Morris, John C.

AU - Janik, John E.

AU - Waldmann, Thomas A.

PY - 2012/1/5

Y1 - 2012/1/5

N2 - Large granular lymphocyte (LGL) leukemia is a clonal lymphoproliferative disease of mature T and natural killer cells. The etiology of LGL leukemia is unknown. IL-15 is an inflammatory cytokine that stimulates T and natural killer cells and is critical for their survival and proliferation. IL-15 signals through a heterotrimeric receptor that is composed of a private receptor, IL-15Rα and IL-2/IL-15Rβ and γ c shared with IL-2. Using a newly developed assay, we demonstrated increased levels of soluble IL-15Rα in the serum of patients with T-LGL leukemia. Furthermore, IL-15Rα mRNA levels were also up-regulated in the PBMCs of these patients. FACS analysis indicated that IL-15Rα was expressed both on monocytes as well as on some CD8 + leukemic cells of the patients. Interestingly, themRNA levels of IFN-α, a known inducer of IL-15Rα, were also up-regulated in patients' PBMCs. Moreover, PBMCs of some T-LGL patients proliferated at higher levels in response to exogenously added IL-15 compared with those of normal donors. In summary, our study demonstrated increased expression of IL-15Rα in T-LGL leukemia. It is conceivable that higher IL-15Rα expression may lower IL-15 response threshold in vivo and, therefore, may contribute to the pathogenesis of the disease.

AB - Large granular lymphocyte (LGL) leukemia is a clonal lymphoproliferative disease of mature T and natural killer cells. The etiology of LGL leukemia is unknown. IL-15 is an inflammatory cytokine that stimulates T and natural killer cells and is critical for their survival and proliferation. IL-15 signals through a heterotrimeric receptor that is composed of a private receptor, IL-15Rα and IL-2/IL-15Rβ and γ c shared with IL-2. Using a newly developed assay, we demonstrated increased levels of soluble IL-15Rα in the serum of patients with T-LGL leukemia. Furthermore, IL-15Rα mRNA levels were also up-regulated in the PBMCs of these patients. FACS analysis indicated that IL-15Rα was expressed both on monocytes as well as on some CD8 + leukemic cells of the patients. Interestingly, themRNA levels of IFN-α, a known inducer of IL-15Rα, were also up-regulated in patients' PBMCs. Moreover, PBMCs of some T-LGL patients proliferated at higher levels in response to exogenously added IL-15 compared with those of normal donors. In summary, our study demonstrated increased expression of IL-15Rα in T-LGL leukemia. It is conceivable that higher IL-15Rα expression may lower IL-15 response threshold in vivo and, therefore, may contribute to the pathogenesis of the disease.

UR - http://www.scopus.com/inward/record.url?scp=84862921558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862921558&partnerID=8YFLogxK

U2 - 10.1182/blood-2011-04-346759

DO - 10.1182/blood-2011-04-346759

M3 - Article

VL - 119

SP - 137

EP - 143

JO - Blood

JF - Blood

SN - 0006-4971

IS - 1

ER -